Welcome to our dedicated page for Corvex news (Ticker: MOVE), a resource for investors and traders seeking the latest updates and insights on Corvex stock.
Corvex, Inc. reports developments in AI cloud computing and GPU-accelerated infrastructure for artificial intelligence workloads. Company news has centered on secure compute clusters, high-throughput storage, managed Kubernetes architecture, confidential computing for data in use, and Secure Model Weights for protected AI inference on third-party GPU infrastructure.
Updates also cover customer deployments, long-term GPU infrastructure arrangements, earnings calls, operating and financial results, and capital-structure actions. Corvex became the public company operating under MOVE after the completed combination with Corvex Legacy Holdings and the name change from Movano Inc. in March 2026.
Movano Health (Nasdaq: MOVE) reported its Q1 2024 financial results, focusing on key initiatives such as enhancing the Evie product, securing FDA 510(k) clearance for the Evie Med Ring, and advancing cuffless blood pressure studies.
The company recently closed a $24 million private placement and generated $852,000 in revenue, shipping 5,305 Evie Rings in Q1. However, it reported an operating loss of $5.8 million, a slight improvement over the $7.2 million loss in Q1 2023. Total cash and equivalents stood at $2.1 million as of March 31, 2024.
Recent milestones include successfully submitting clinical trial results for the Evie Med Ring and planning a new blood pressure study for June 2024. The company expects an FDA decision on the Evie Med Ring in July 2024.
Movano Health submitted exemplary SpO2 clinical trial results to the FDA as part of its 510(k) filing for the Evie Med Ring pulse oximeter. The Company aims to disrupt the wearables industry and unlock partnership opportunities with potential FDA clearance expected in July 2024. The recent clinical trial results demonstrated high accuracy across skin tones, surpassing FDA guidelines and outperforming hospital-grade reference pulse oximeters. Movano Health closed a $24 million private placement, received a strategic investment from a major medical device company, and signed collaboration agreements to advance its wearable medical device solutions.
Movano Health (Nasdaq: MOVE) will release its first quarter 2024 financial results on May 15, 2024, after the market closes. The company will host a conference call and webcast at 2:00 pm PT/5:00 pm ET to discuss the results and provide a business update. Attendees can join via webcast or phone. An archived webcast will be available on the company's website.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.